Imperial Petroleum earnings missed, revenue fell short of estimates
We haven't written up this one. Investing.com has the full story — the link below goes straight to it.
More in Finance & Markets
Viking Therapeutics Trades Well Below Its Wall Street Targets. Here's the Skeptics' Case.
Investors always need to appreciate risk before buying into any clinical-stage biopharmaceutical company.
Bill Gates Says He Still Won't Invest in Crypto, Calls It a "Pure Mania-Driven Asset." Here's Why He's Right.
Key PointsBitcoin’s massive gains don’t eliminate its fundamental investment risks.
Cerebras Has a $25.4 Billion Backlog, and One OpenAI Agreement Is Behind Much of It
Key PointsCerebras grew its second-quarter adjusted revenue 103% year over year to $209.9 million.
Viking Therapeutics Trades Well Below Its Wall Street Targets. Here's the Skeptics' Case.
Key PointsViking Therapeutics has significant upside potential based on Wall Street targets.
Resideo SVP Mehta Buys 10,928 Shares in $226,000 Direct Purchase
Mehta's acquisition expands his direct stake by 24%.
- Senior Vice President Amit Ashvin Mehta purchased 10,928 shares on August 17, 2026.
- Transaction cost $226,000 at $20.68 per share, slightly below market closing price.
